# FDA Warning Letter: Sircle Laboratories, LLC
> 2021-10-19 · Office of Pharmaceutical Quality Operations, Division II · `e8bde50bee02a440`
## Letter
- **Company:** Sircle Laboratories, LLC
- **Posted Date:** 2021-10-19
- **Letter Issue Date:** 2021-09-21
- **Issuing Office:** Office of Pharmaceutical Quality Operations, Division II
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*